Paper3940501
Treatment of severe reflux esophagitis with cimetidine and metoclopramide.
Lieberman DA and 1 other. Ann Intern Med, 1986. Cited by 89 papers, by iCite.
Cite this record
ConductScience Library. Treatment of severe reflux esophagitis with cimetidine and metoclopramide. Papers, record 3940501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3940501
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cimetidine | Major topic |
| Esophagitis, Peptic | Major topic |
| Metoclopramide | Major topic |
| Biopsy | |
| Double-Blind Method | |
| Drug Evaluation | |
| Drug Therapy, Combination | |
| Esophagogastric Junction | |
| Esophagoscopy | |
| Female | |
| Humans | |
| Hydrogen-Ion Concentration | |
| Male | |
| Manometry | |
| Middle Aged | |
| Pressure | |
| Random Allocation |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RR00334 | NCRR NIH HHS | United States | PubMed |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39282236 | GERD: Latest update on acid-suppressant drugs. | Curr Res Pharmacol Drug Discov | 2024 | https://conductscience.org/library/papers/39282236 | PubMed |
| 28577245 | From Harmful Treatment to Secondary Gain: Adverse Event Reporting in Dyspepsia and Gastroparesis. | Dig Dis Sci | 2017 | https://conductscience.org/library/papers/28577245 | PubMed |
| 26441276 | GRG Profiles: David A. Lieberman. | Dig Dis Sci | 2015 | https://conductscience.org/library/papers/26441276 | PubMed |
| 21673949 | Prokinetic drug utility in the treatment of gastroesophageal reflux esophagitis: a systematic review of randomized controlled trials. | Open Med | 2007 | https://conductscience.org/library/papers/21673949 | PubMed |
| 7601011 | Pharmacological management of gastro-oesophageal reflux disease. | Drugs | 1995 | https://conductscience.org/library/papers/7601011 | PubMed |
| 3338365 | 24-hour esophageal pH monitoring before and after medical therapy for reflux esophagitis. | Dig Dis Sci | 1988 | https://conductscience.org/library/papers/3338365 | PubMed |
| 3294124 | Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial. | Gut | 1988 | https://conductscience.org/library/papers/3294124 | PubMed |
| 2573565 | Histamine-2-receptor antagonists in gastro-oesophageal reflux. | Gut | 1989 | https://conductscience.org/library/papers/2573565 | PubMed |
| 2191848 | Treatment approaches to reflux oesophagitis. | Drugs | 1990 | https://conductscience.org/library/papers/2191848 | PubMed |
| 1346769 | Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease. | Gut | 1992 | https://conductscience.org/library/papers/1346769 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3940501
GET https://conductscience.org/api/papers/v1/3940501/authors